Evidence map›Paper›PMID 36551122›Full record

ReviewBiosensors2022

Recent Advances in Nanotechnology for the Management of

Mahmood Barani, Hadis Fathizadeh, Hassan Arkaban, Davood Kalantar-Neyestanaki, Majid Reza Akbarizadeh, Abduladheem Turki Jalil, Reza Akhavan-Sigari

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Biosensors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Antibiotic resistance inFrontiers in microbiology · 2026
    Review
  4. Article
  5. TiOMicroorganisms · 2024
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 4 countries.

Mahmood BaraniStudent Research Committee, Kerman University of Medical Sciences, Kerman 7616913555, Iran.ORCID 0000-0002-1711-2522
Hadis FathizadehDepartment of Laboratory Sciences, Sirjan School of Medical Sciences, Sirjan 7616916338, Iran.
Hassan ArkabanDepartment of Chemistry, University of Isfahan, Isfahan 8174673441, Iran.
Davood Kalantar-NeyestanakiMedical Mycology and Bacteriology Research Center, Kerman University of Medical Sciences, Kerman 7616913555, Iran.
Majid Reza AkbarizadehDepartment of Pediatric, Amir Al Momenin Hospital, Zabol University of Medical Sciences, Zabol 9861663335, Iran.
Abduladheem Turki JalilMedical Laboratories Techniques Department, Al-Mustaqbal University College, Babylon, Hilla 51001, Iraq.ORCID 0000-0001-8403-7465
Reza Akhavan-SigariDepartment of Neurosurgery, University Medical Center Tuebingen, 72076 Tuebingen, Germany.
Kerman University of Medical Sciences · IRAlsalam University College · IQSirjan University of Technology · IRUniversity of Isfahan · IRWarsaw Management University · PLZabol University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Klebsiella pneumoniaeUrinary Tract InfectionsAnti-Bacterial AgentsHumansNanotechnologyAnti-Bacterial AgentsantibacterialdetectionKlebsiella pneumoniaemetallic nanoparticlesnanotechnology

Identifiers

PMID36551122
PMCPMC9776335
OpenAlexW4311134464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.